Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma

6 Sept 2024

Abstract excerpt

Liver cancer is a global health challenge, causing a significant social-economic burden. Hepatocellular carcinoma (HCC) is the predominant type of primary liver cancer, which is highly heterogeneous in terms of molecular and cellular signatures. Early-stage or small tumors are typically treated with surgery or ablation. Currently, chemotherapies and immunotherapies are the best treatments for unresectable tumors...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatocellular Carcinoma Treatment and Prognosis
Share to Liver Disease Diagnosis and Treatment
Share to Liver physiology and pathology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39242496
DOI: 10.1186/s12943-024-02101-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarkers for diagnosis and therapeutic options in hepatocellular carcinomaPMID 39242496Read ↗

Liquid biopsies for hepatocellular carcinoma.Semantic proximity Read ↗

Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.Semantic proximity Read ↗

Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNASemantic proximity Read ↗

Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular CarcinomaSemantic proximity Read ↗

Emerging evidence of molecular biomarkers in hepatocellular carcinoma.Semantic proximity Read ↗

Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized MedicineSemantic proximity Read ↗

Recent developments in molecular targeted therapies for hepatocellular carcinoma in the genomic era.Semantic proximity Read ↗

Using cell-free DNA for HCC surveillance and prognosisSemantic proximity Read ↗

A clinical and pathological update on hepatocellular carcinomaSemantic proximity Read ↗

Circulating tumor DNA and its role in detection, prognosis and therapeutics of hepatocellular carcinomaSemantic proximity Read ↗

Exploration of Practical Biomarkers for Systemic Drug Therapy for Hepatocellular CarcinomaSemantic proximity Read ↗

Hepatocellular carcinoma: old friends and new tricksSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.